Please login to the form below

Not currently logged in
Email:
Password:

Yale Cancer Center

This page shows the latest Yale Cancer Center news and features for those working in and with pharma, biotech and healthcare.

Yale Cancer Center joins BMS’ II-ON

Yale Cancer Center joins BMS’ II-ON

Yale Cancer Center joins BMS’ II-ON. Becomes the 16. th. institute to join the network. ... Bristol-Myers Squibb has bolstered the International Immuno-Oncology Network (II-ON) with the addition of the Yale Cancer Center.

Latest news

  • Boehringer partners with US universities Boehringer partners with US universities

    Boehringer partners with US universities. Will work with Yale and Vanderbilt on cancer projects. ... The project will be led by Dr Lieping Chen, director of cancer immunology at the Yale Cancer Center, who has experience in the growing area of anti-PD-1

  • Archive listing

    Yale Cancer Center joins BMS’ II-ON. ... The cancer drug combo met one of its primary endpoints in NSCLC patients. .

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics